AGAPE ATP CORPORATION Increase (Decrease) in Accounts Receivable
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Accounts Receivable of -$4.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $3.01K.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$7.76K.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $5.15K, a 85.13% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$5.82K, a 197.70% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for fiscal 2025 was -$32.13K, a 213.56% decline from fiscal 2024.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was $28.30K, a 47.25% decline from fiscal 2023.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $53.64K, a 1799.47% increase from fiscal 2022.
- AGAPE ATP CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was $2.82K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.75K 10-Q · filed 2026-08-14 | $400.00 derived: sum of 3 quarters · filed 2026-08-14 | -$5.42K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$7.76K 10-Q · filed 2026-05-15 | -$2.61K derived: sum of 2 quarters · filed 2026-05-15 | -$8.44K derived: sum of 3 quarters · filed 2026-05-15 | -$35.53K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $5.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$670.00 derived: sum of 2 quarters · filed 2026-04-13 | -$27.77K derived: sum of 3 quarters · filed 2026-08-14 | -$32.13K 10-K · filed 2026-04-13 | |
| 2025-09-30 | -$5.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$32.92K derived: sum of 2 quarters · filed 2026-08-14 | -$37.28K 10-Q · filed 2025-11-13 | -$2.64K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$27.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$31.46K 10-Q · filed 2026-08-14 | -$25.48K 10-Q · filed 2025-08-13 | $3.19K derived: sum of 3 quarters · filed 2026-08-14 | $9.14K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$4.37K 10-Q · filed 2026-05-15 | $30.28K derived: sum of 2 quarters · filed 2026-05-15 | $36.24K derived: sum of 3 quarters · filed 2026-05-15 | $40.16K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $34.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $40.61K derived: sum of 2 quarters · filed 2026-04-13 | $44.52K derived: sum of 3 quarters · filed 2026-04-13 | $28.30K 10-K · filed 2026-04-13 | |
| 2024-09-30 | $5.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.87K derived: sum of 2 quarters · filed 2025-11-13 | -$6.35K 10-Q · filed 2025-11-13 | $26.49K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $3.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$12.31K 10-Q · filed 2025-08-13 | $20.53K derived: sum of 3 quarters · filed 2025-08-13 | $38.58K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$16.23K 10-Q · filed 2025-05-15 | $16.61K derived: sum of 2 quarters · filed 2025-05-15 | $34.66K derived: sum of 3 quarters · filed 2025-05-15 | $36.20K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $32.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $50.89K derived: sum of 2 quarters · filed 2025-03-31 | $52.43K derived: sum of 3 quarters · filed 2025-03-31 | $53.64K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $18.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $19.59K derived: sum of 2 quarters · filed 2024-11-14 | $20.80K 10-Q · filed 2024-11-14 | $21.80K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.75K 10-Q · filed 2024-08-14 | $3.75K derived: sum of 3 quarters · filed 2024-08-14 | $5.36K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $1.21K 10-Q · filed 2024-05-14 | $2.21K derived: sum of 2 quarters · filed 2024-05-14 | $3.82K derived: sum of 3 quarters · filed 2024-05-14 | $672.00 derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $996.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.61K derived: sum of 2 quarters · filed 2024-04-01 | -$539.00 derived: sum of 3 quarters · filed 2024-04-01 | $2.82K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.53K derived: sum of 2 quarters · filed 2023-11-14 | $1.83K 10-Q · filed 2023-11-14 | $2.28K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $214.00 10-Q · filed 2023-08-14 | $667.00 derived: sum of 3 quarters · filed 2023-08-14 | $2.04K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $3.36K 10-Q · filed 2023-05-15 | $3.82K derived: sum of 2 quarters · filed 2023-05-15 | $5.19K derived: sum of 3 quarters · filed 2023-05-15 | $8.54K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $453.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.83K derived: sum of 2 quarters · filed 2023-03-31 | $5.17K derived: sum of 3 quarters · filed 2023-03-31 | -$167.57K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.72K derived: sum of 2 quarters · filed 2022-11-14 | -$168.02K 10-Q · filed 2022-11-14 | -$274.75K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $3.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$169.39K 10-Q · filed 2022-08-11 | -$276.12K derived: sum of 3 quarters · filed 2022-08-11 | -$326.79K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$172.74K 10-Q · filed 2022-05-13 | -$279.47K derived: sum of 2 quarters · filed 2022-07-05 | -$330.14K derived: sum of 3 quarters · filed 2022-07-05 | ||
| 2020-12-31 | -$106.73K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | -$157.40K derived: sum of 2 quarters · filed 2022-07-05 | $165.15K 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | -$50.67K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $271.88K 10-Q/A · filed 2022-07-05 | |||
| 2020-06-30 | $322.55K 10-Q · filed 2021-08-13 | ||||
| 2019-09-30 | $116.97K 10-Q · filed 2019-11-12 | $442.05K derived: sum of 2 quarters · filed 2019-12-02 | |||
| 2019-06-30 | $325.07K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-02 | $511.61K 10-K/A · filed 2019-12-02 | |||
| 2019-03-31 | $186.54K 10-Q · filed 2019-05-13 | ||||
| 2018-09-30 | $13.26K 10-Q · filed 2019-11-12 | ||||
| 2018-03-31 | -$437.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | -$438.05K derived: sum of 2 quarters · filed 2019-05-13 | $52.41K 10-Q · filed 2019-05-13 | ||
| 2017-12-31 | -$628.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-15 | $489.84K 10-Q · filed 2019-02-15 | |||
| 2017-09-30 | $490.47K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |